

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 9.50900458 |
| 2 | * energy coupled proton transport, down electrochemical gradient (GO:0015985) | 8.87314949 |
| 3 | * ATP synthesis coupled proton transport (GO:0015986) | 8.87314949 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 7.70912557 |
| 5 | * respiratory electron transport chain (GO:0022904) | 7.57554265 |
| 6 | * electron transport chain (GO:0022900) | 7.39648742 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 7.29065706 |
| 8 | * oxidative phosphorylation (GO:0006119) | 6.46761069 |
| 9 | NADH metabolic process (GO:0006734) | 5.54256708 |
| 10 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.17547359 |
| 11 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.15655311 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.05069029 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 5.05069029 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.05069029 |
| 15 | * ATP biosynthetic process (GO:0006754) | 5.04469665 |
| 16 | regulation of cofactor metabolic process (GO:0051193) | 4.95675970 |
| 17 | regulation of coenzyme metabolic process (GO:0051196) | 4.95675970 |
| 18 | protein complex biogenesis (GO:0070271) | 4.86571204 |
| 19 | aerobic respiration (GO:0009060) | 4.66622352 |
| 20 | succinate metabolic process (GO:0006105) | 4.66184169 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.65778445 |
| 22 | inner mitochondrial membrane organization (GO:0007007) | 4.55501297 |
| 23 | heart contraction (GO:0060047) | 4.48424789 |
| 24 | heart process (GO:0003015) | 4.48424789 |
| 25 | * purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.48317265 |
| 26 | * purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.47308275 |
| 27 | sarcomere organization (GO:0045214) | 4.42747252 |
| 28 | cullin deneddylation (GO:0010388) | 4.33587387 |
| 29 | muscle filament sliding (GO:0030049) | 4.20845513 |
| 30 | actin-myosin filament sliding (GO:0033275) | 4.20845513 |
| 31 | regulation of mitochondrial translation (GO:0070129) | 4.17944189 |
| 32 | oxaloacetate metabolic process (GO:0006107) | 4.13767747 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.11273731 |
| 34 | ubiquinone biosynthetic process (GO:0006744) | 4.10081532 |
| 35 | quinone biosynthetic process (GO:1901663) | 4.10081532 |
| 36 | chaperone-mediated protein transport (GO:0072321) | 4.06434448 |
| 37 | * hydrogen ion transmembrane transport (GO:1902600) | 4.06179415 |
| 38 | * ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.03968615 |
| 39 | protein deneddylation (GO:0000338) | 4.00477460 |
| 40 | cellular respiration (GO:0045333) | 3.95444657 |
| 41 | cardiac myofibril assembly (GO:0055003) | 3.91578854 |
| 42 | * purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.81009491 |
| 43 | * purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.81009491 |
| 44 | ribosomal large subunit biogenesis (GO:0042273) | 3.80239269 |
| 45 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.79822346 |
| 46 | regulation of sulfur metabolic process (GO:0042762) | 3.74633253 |
| 47 | rRNA modification (GO:0000154) | 3.71330999 |
| 48 | ubiquinone metabolic process (GO:0006743) | 3.67258077 |
| 49 | establishment of integrated proviral latency (GO:0075713) | 3.64819842 |
| 50 | * nucleoside triphosphate biosynthetic process (GO:0009142) | 3.63193385 |
| 51 | regulation of cellular respiration (GO:0043457) | 3.57710281 |
| 52 | ribosomal small subunit assembly (GO:0000028) | 3.52495065 |
| 53 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.50892983 |
| 54 | * proton transport (GO:0015992) | 3.50843076 |
| 55 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.50272996 |
| 56 | cardiac muscle contraction (GO:0060048) | 3.48928523 |
| 57 | * mitochondrial transport (GO:0006839) | 3.47925258 |
| 58 | branched-chain amino acid catabolic process (GO:0009083) | 3.46638008 |
| 59 | * hydrogen transport (GO:0006818) | 3.45861608 |
| 60 | regulation of oxidative phosphorylation (GO:0002082) | 3.45111336 |
| 61 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.45008337 |
| 62 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.45008337 |
| 63 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.44052096 |
| 64 | myofibril assembly (GO:0030239) | 3.43686936 |
| 65 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.39852245 |
| 66 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.39375436 |
| 67 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.39064671 |
| 68 | actin-mediated cell contraction (GO:0070252) | 3.36510498 |
| 69 | cotranslational protein targeting to membrane (GO:0006613) | 3.36366176 |
| 70 | positive regulation of ligase activity (GO:0051351) | 3.35344072 |
| 71 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.34306858 |
| 72 | translation (GO:0006412) | 3.33455410 |
| 73 | protein targeting to ER (GO:0045047) | 3.30024525 |
| 74 | termination of RNA polymerase III transcription (GO:0006386) | 3.29697425 |
| 75 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.29697425 |
| 76 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.29143976 |
| 77 | proteasome assembly (GO:0043248) | 3.25600238 |
| 78 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.25424247 |
| 79 | respiratory chain complex IV assembly (GO:0008535) | 3.24323708 |
| 80 | regulation of relaxation of muscle (GO:1901077) | 3.24193387 |
| 81 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.24026716 |
| 82 | cardiac muscle cell development (GO:0055013) | 3.21556842 |
| 83 | aldehyde catabolic process (GO:0046185) | 3.21195504 |
| 84 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.20665742 |
| 85 | protein neddylation (GO:0045116) | 3.20163643 |
| 86 | * ribonucleoside monophosphate biosynthetic process (GO:0009156) | 3.20106250 |
| 87 | protein localization to endoplasmic reticulum (GO:0070972) | 3.17941566 |
| 88 | protein targeting to mitochondrion (GO:0006626) | 3.17781420 |
| 89 | lysine catabolic process (GO:0006554) | 3.16066597 |
| 90 | lysine metabolic process (GO:0006553) | 3.16066597 |
| 91 | translational termination (GO:0006415) | 3.15962361 |
| 92 | ribosome assembly (GO:0042255) | 3.15921800 |
| 93 | viral transcription (GO:0019083) | 3.15614150 |
| 94 | * generation of precursor metabolites and energy (GO:0006091) | 3.14255752 |
| 95 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.14047337 |
| 96 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.11961837 |
| 97 | establishment of protein localization to mitochondrion (GO:0072655) | 3.11865330 |
| 98 | * purine ribonucleoside biosynthetic process (GO:0046129) | 3.09884849 |
| 99 | * purine nucleoside biosynthetic process (GO:0042451) | 3.09884849 |
| 100 | protein localization to mitochondrion (GO:0070585) | 3.09025046 |
| 101 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.08652455 |
| 102 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.06747624 |
| 103 | pseudouridine synthesis (GO:0001522) | 3.05516756 |
| 104 | rRNA methylation (GO:0031167) | 3.05196702 |
| 105 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.04758100 |
| 106 | CENP-A containing nucleosome assembly (GO:0034080) | 3.04117980 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.04084296 |
| 108 | 2-oxoglutarate metabolic process (GO:0006103) | 3.02349669 |
| 109 | * nucleoside monophosphate biosynthetic process (GO:0009124) | 3.01879528 |
| 110 | cytochrome complex assembly (GO:0017004) | 3.00013715 |
| 111 | cellular component biogenesis (GO:0044085) | 2.98633035 |
| 112 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.98605768 |
| 113 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.98063205 |
| 114 | translational initiation (GO:0006413) | 2.97098208 |
| 115 | negative regulation of ligase activity (GO:0051352) | 2.96935567 |
| 116 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.96935567 |
| 117 | regulation of ligase activity (GO:0051340) | 2.96084959 |
| 118 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.96023240 |
| 119 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.96023240 |
| 120 | DNA double-strand break processing (GO:0000729) | 2.95879339 |
| 121 | chromatin remodeling at centromere (GO:0031055) | 2.95574536 |
| 122 | purine nucleobase biosynthetic process (GO:0009113) | 2.95519936 |
| 123 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.93977804 |
| 124 | formation of translation preinitiation complex (GO:0001731) | 2.93702657 |
| 125 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.93559431 |
| 126 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.93530483 |
| 127 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.93530483 |
| 128 | cardiac cell development (GO:0055006) | 2.92417207 |
| 129 | branched-chain amino acid metabolic process (GO:0009081) | 2.91410021 |
| 130 | muscle tissue morphogenesis (GO:0060415) | 2.90640429 |
| 131 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.90110124 |
| 132 | translational elongation (GO:0006414) | 2.89057964 |
| 133 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.87386842 |
| 134 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.87386842 |
| 135 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.87386842 |
| 136 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.87357796 |
| 137 | spliceosomal snRNP assembly (GO:0000387) | 2.87029136 |
| 138 | quinone metabolic process (GO:1901661) | 2.85703552 |
| 139 | amino acid salvage (GO:0043102) | 2.83102856 |
| 140 | L-methionine salvage (GO:0071267) | 2.83102856 |
| 141 | L-methionine biosynthetic process (GO:0071265) | 2.83102856 |
| 142 | regulation of cellular amine metabolic process (GO:0033238) | 2.81576522 |
| 143 | establishment of viral latency (GO:0019043) | 2.79853128 |
| 144 | peptidyl-histidine modification (GO:0018202) | 2.79836056 |
| 145 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.75976530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.20685718 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.25685592 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.14230180 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.11744808 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.04555416 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.97368136 |
| 7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.74336437 |
| 8 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71801135 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.61081293 |
| 10 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.54664117 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.50980658 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.47766901 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.41819448 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.07567735 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.98764483 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.87787179 |
| 17 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.86722302 |
| 18 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.82448113 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.66135534 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.55372080 |
| 21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.46368125 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.45898100 |
| 23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.43717037 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.43391486 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29351067 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28375466 |
| 27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.22223553 |
| 28 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20621230 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16160835 |
| 30 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.08290660 |
| 31 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04627472 |
| 32 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.03178124 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99430128 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.94788799 |
| 35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.92500701 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.89600238 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.85109821 |
| 38 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78247356 |
| 39 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.78080056 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77814364 |
| 41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.71793820 |
| 42 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.58984719 |
| 43 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57509377 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.57082491 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.55359264 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50915486 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.47920820 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36444404 |
| 49 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35987100 |
| 50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35609586 |
| 51 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.34628813 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33736658 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31332435 |
| 54 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29676218 |
| 55 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.27524615 |
| 56 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27254331 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25319309 |
| 58 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24921426 |
| 59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.22582408 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22346767 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21365963 |
| 62 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20607743 |
| 63 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.19912942 |
| 64 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19462308 |
| 65 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18744365 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12801732 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12393864 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10723169 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09637293 |
| 70 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.08789113 |
| 71 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07444353 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06634557 |
| 73 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05367494 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01718433 |
| 75 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01335685 |
| 76 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00200913 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.99125573 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98910837 |
| 79 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.98282507 |
| 80 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97671487 |
| 81 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97616229 |
| 82 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96910319 |
| 83 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.96535333 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93761693 |
| 85 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92694565 |
| 86 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92679634 |
| 87 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91761111 |
| 88 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91482618 |
| 89 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91073228 |
| 90 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.90785753 |
| 91 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89921351 |
| 92 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.89667166 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89535938 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87352680 |
| 95 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86695571 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.86324561 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86075501 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84020569 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83525571 |
| 100 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83459841 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82218489 |
| 102 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.81627237 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.79296616 |
| 104 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.78765121 |
| 105 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77788979 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77556895 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.77011576 |
| 108 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.76582102 |
| 109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.75701973 |
| 110 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.75570040 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.75162989 |
| 112 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.73069540 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.72046168 |
| 114 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.71670516 |
| 115 | FUS_26573619_Chip-Seq_HEK293_Human | 0.71168729 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70726659 |
| 117 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.70613385 |
| 118 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.70342813 |
| 119 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.70321530 |
| 120 | GATA1_22025678_ChIP-Seq_K562_Human | 0.70137057 |
| 121 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.69692290 |
| 122 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.69117725 |
| 123 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.68145983 |
| 124 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.67922726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.00435454 |
| 2 | MP0003646_muscle_fatigue | 4.91661697 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.73643431 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.25856865 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.97623614 |
| 6 | MP0000751_myopathy | 3.81326213 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.71784709 |
| 8 | MP0000749_muscle_degeneration | 3.60951387 |
| 9 | MP0005330_cardiomyopathy | 3.37950912 |
| 10 | MP0008058_abnormal_DNA_repair | 3.31850586 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.10100180 |
| 12 | MP0006035_abnormal_mitochondrial_morpho | 2.82345911 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.66876020 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.35234672 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.34627981 |
| 16 | MP0003221_abnormal_cardiomyocyte_apopto | 2.32547775 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.30467000 |
| 18 | MP0001529_abnormal_vocalization | 2.27725578 |
| 19 | MP0004484_altered_response_of | 2.19730773 |
| 20 | MP0004087_abnormal_muscle_fiber | 2.16179369 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 2.12906381 |
| 22 | MP0005385_cardiovascular_system_phenoty | 2.12906381 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.06374457 |
| 24 | MP0004043_abnormal_pH_regulation | 2.06160120 |
| 25 | MP0003111_abnormal_nucleus_morphology | 2.06106514 |
| 26 | MP0002269_muscular_atrophy | 2.04054981 |
| 27 | MP0003077_abnormal_cell_cycle | 1.98769153 |
| 28 | MP0003786_premature_aging | 1.97474244 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.96518075 |
| 30 | MP0006138_congestive_heart_failure | 1.96440516 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.91451588 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.80265149 |
| 33 | MP0003186_abnormal_redox_activity | 1.72388080 |
| 34 | MP0004147_increased_porphyrin_level | 1.71278365 |
| 35 | MP0002938_white_spotting | 1.70037635 |
| 36 | MP0004085_abnormal_heartbeat | 1.64946294 |
| 37 | MP0005369_muscle_phenotype | 1.63933682 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.63864980 |
| 39 | MP0003195_calcinosis | 1.63667482 |
| 40 | MP0000747_muscle_weakness | 1.62871247 |
| 41 | MP0005266_abnormal_metabolism | 1.62808700 |
| 42 | MP0004130_abnormal_muscle_cell | 1.61951650 |
| 43 | MP0002102_abnormal_ear_morphology | 1.59587550 |
| 44 | MP0003941_abnormal_skin_development | 1.59419655 |
| 45 | MP0010630_abnormal_cardiac_muscle | 1.57984213 |
| 46 | MP0008007_abnormal_cellular_replicative | 1.53455345 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 1.51192449 |
| 48 | MP0005332_abnormal_amino_acid | 1.49893780 |
| 49 | MP0004233_abnormal_muscle_weight | 1.49187974 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.45623744 |
| 51 | MP0003567_abnormal_fetal_cardiomyocyte | 1.37995900 |
| 52 | MP0009697_abnormal_copulation | 1.33939860 |
| 53 | MP0004957_abnormal_blastocyst_morpholog | 1.29769252 |
| 54 | MP0003123_paternal_imprinting | 1.29681951 |
| 55 | MP0008995_early_reproductive_senescence | 1.27094087 |
| 56 | MP0005360_urolithiasis | 1.21693838 |
| 57 | MP0002160_abnormal_reproductive_system | 1.09970888 |
| 58 | MP0001764_abnormal_homeostasis | 1.09818972 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.06969476 |
| 60 | MP0003122_maternal_imprinting | 1.06881180 |
| 61 | MP0003828_pulmonary_edema | 1.05779323 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.05224445 |
| 63 | MP0000230_abnormal_systemic_arterial | 1.05010187 |
| 64 | MP0005408_hypopigmentation | 1.03364252 |
| 65 | MP0003136_yellow_coat_color | 1.01523524 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 0.99625518 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.98260761 |
| 68 | MP0001905_abnormal_dopamine_level | 0.97880844 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95488139 |
| 70 | MP0000358_abnormal_cell_content/ | 0.94026098 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93352379 |
| 72 | MP0005165_increased_susceptibility_to | 0.92898433 |
| 73 | MP0003011_delayed_dark_adaptation | 0.90404700 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.89814787 |
| 75 | MP0005376_homeostasis/metabolism_phenot | 0.89270201 |
| 76 | MP0009379_abnormal_foot_pigmentation | 0.89182244 |
| 77 | MP0001727_abnormal_embryo_implantation | 0.89118725 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.88193514 |
| 79 | MP0002090_abnormal_vision | 0.86956655 |
| 80 | MP0005535_abnormal_body_temperature | 0.86432463 |
| 81 | MP0004142_abnormal_muscle_tone | 0.85629898 |
| 82 | MP0005253_abnormal_eye_physiology | 0.84499316 |
| 83 | MP0002638_abnormal_pupillary_reflex | 0.83595570 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.82740409 |
| 85 | MP0008057_abnormal_DNA_replication | 0.82431316 |
| 86 | MP0001661_extended_life_span | 0.80348248 |
| 87 | MP0003283_abnormal_digestive_organ | 0.79750563 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.79612995 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.77127351 |
| 90 | MP0001968_abnormal_touch/_nociception | 0.77077403 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.76921240 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.76664472 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.76493964 |
| 94 | MP0000516_abnormal_urinary_system | 0.76493964 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.76063458 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.75890609 |
| 97 | MP0005670_abnormal_white_adipose | 0.75304367 |
| 98 | MP0001929_abnormal_gametogenesis | 0.74930422 |
| 99 | MP0000343_altered_response_to | 0.74361303 |
| 100 | MP0005410_abnormal_fertilization | 0.74210308 |
| 101 | MP0002139_abnormal_hepatobiliary_system | 0.74202501 |
| 102 | MP0005386_behavior/neurological_phenoty | 0.73927275 |
| 103 | MP0004924_abnormal_behavior | 0.73927275 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.72550011 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.72495120 |
| 106 | MP0001881_abnormal_mammary_gland | 0.72333809 |
| 107 | MP0001697_abnormal_embryo_size | 0.71762140 |
| 108 | MP0005171_absent_coat_pigmentation | 0.71662125 |
| 109 | MP0001666_abnormal_nutrient_absorption | 0.71600391 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.71198888 |
| 111 | MP0003880_abnormal_central_pattern | 0.70156243 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.69020400 |
| 113 | MP0003315_abnormal_perineum_morphology | 0.68882736 |
| 114 | MP0000647_abnormal_sebaceous_gland | 0.67836657 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.67368378 |
| 116 | MP0003252_abnormal_bile_duct | 0.66751768 |
| 117 | MP0002822_catalepsy | 0.66294849 |
| 118 | MP0001756_abnormal_urination | 0.65450370 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.63494426 |
| 120 | MP0005451_abnormal_body_composition | 0.60644336 |
| 121 | MP0008932_abnormal_embryonic_tissue | 0.59403001 |
| 122 | MP0003693_abnormal_embryo_hatching | 0.59240674 |
| 123 | MP0000266_abnormal_heart_morphology | 0.58395759 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.58358263 |
| 125 | MP0002163_abnormal_gland_morphology | 0.55797805 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.55712650 |
| 127 | MP0000372_irregular_coat_pigmentation | 0.50650283 |
| 128 | MP0005365_abnormal_bile_salt | 0.48875515 |
| 129 | MP0002971_abnormal_brown_adipose | 0.47768660 |
| 130 | MP0001984_abnormal_olfaction | 0.46440523 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.46036984 |
| 132 | MP0001730_embryonic_growth_arrest | 0.46010466 |
| 133 | MP0003718_maternal_effect | 0.44001922 |
| 134 | MP0002736_abnormal_nociception_after | 0.42214344 |
| 135 | MP0010094_abnormal_chromosome_stability | 0.41868341 |
| 136 | MP0005452_abnormal_adipose_tissue | 0.41212899 |
| 137 | MP0003984_embryonic_growth_retardation | 0.40663987 |
| 138 | MP0003121_genomic_imprinting | 0.40485728 |
| 139 | MP0008872_abnormal_physiological_respon | 0.40325469 |
| 140 | MP0005377_hearing/vestibular/ear_phenot | 0.38651205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.92011682 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.68962949 |
| 3 | Acute encephalopathy (HP:0006846) | 6.06139959 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.81844959 |
| 5 | Progressive macrocephaly (HP:0004481) | 5.78536821 |
| 6 | Hepatic necrosis (HP:0002605) | 5.56548853 |
| 7 | Increased CSF lactate (HP:0002490) | 5.46375344 |
| 8 | Hepatocellular necrosis (HP:0001404) | 5.45758046 |
| 9 | Abnormality of glycolysis (HP:0004366) | 5.22516526 |
| 10 | Increased serum pyruvate (HP:0003542) | 5.22516526 |
| 11 | Cerebral edema (HP:0002181) | 4.76283378 |
| 12 | Lactic acidosis (HP:0003128) | 4.26534672 |
| 13 | Exercise intolerance (HP:0003546) | 4.15170216 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 4.04454628 |
| 15 | Sudden death (HP:0001699) | 4.01337824 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.00644877 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.00644877 |
| 18 | Respiratory failure (HP:0002878) | 3.97994386 |
| 19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.95741005 |
| 20 | Increased hepatocellular lipid droplets (HP:0006565) | 3.85996836 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 3.84391484 |
| 22 | Myoglobinuria (HP:0002913) | 3.83730104 |
| 23 | Palpitations (HP:0001962) | 3.82163485 |
| 24 | Increased serum lactate (HP:0002151) | 3.81702786 |
| 25 | Increased muscle lipid content (HP:0009058) | 3.78951132 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 3.64264508 |
| 27 | Rhabdomyolysis (HP:0003201) | 3.55379687 |
| 28 | Exercise-induced myalgia (HP:0003738) | 3.49351241 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.44547038 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 3.40172317 |
| 31 | Hyperalaninemia (HP:0003348) | 3.40172317 |
| 32 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.40172317 |
| 33 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.39537767 |
| 34 | Pheochromocytoma (HP:0002666) | 3.33870057 |
| 35 | Neuroendocrine neoplasm (HP:0100634) | 3.28703279 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 3.27900058 |
| 37 | Ventricular tachycardia (HP:0004756) | 3.25904250 |
| 38 | Leukodystrophy (HP:0002415) | 3.20972768 |
| 39 | Conjunctival hamartoma (HP:0100780) | 3.19571513 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.15760546 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.15760546 |
| 42 | Optic disc pallor (HP:0000543) | 3.12386022 |
| 43 | Type I transferrin isoform profile (HP:0003642) | 3.10072030 |
| 44 | Lethargy (HP:0001254) | 2.93542377 |
| 45 | Lipoatrophy (HP:0100578) | 2.89316574 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.87212378 |
| 47 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.84390397 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.82928664 |
| 49 | Ketoacidosis (HP:0001993) | 2.82250135 |
| 50 | Renal Fanconi syndrome (HP:0001994) | 2.82063373 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.80351248 |
| 52 | Atrial fibrillation (HP:0005110) | 2.80322792 |
| 53 | CNS demyelination (HP:0007305) | 2.79198092 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.79048657 |
| 55 | Abnormal number of erythroid precursors (HP:0012131) | 2.76229697 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.68592741 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.67086887 |
| 58 | Glycosuria (HP:0003076) | 2.67086887 |
| 59 | Neoplasm of the adrenal gland (HP:0100631) | 2.67043529 |
| 60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.66457258 |
| 61 | Abnormality of the calf musculature (HP:0001430) | 2.66050903 |
| 62 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.64287561 |
| 63 | Supraventricular tachycardia (HP:0004755) | 2.62472252 |
| 64 | Primary atrial arrhythmia (HP:0001692) | 2.58812885 |
| 65 | Dilated cardiomyopathy (HP:0001644) | 2.53467137 |
| 66 | Supraventricular arrhythmia (HP:0005115) | 2.52881110 |
| 67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52348269 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52348269 |
| 69 | Abnormal protein glycosylation (HP:0012346) | 2.52348269 |
| 70 | Abnormal glycosylation (HP:0012345) | 2.52348269 |
| 71 | Respiratory difficulties (HP:0002880) | 2.52022735 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.51377059 |
| 73 | Methylmalonic aciduria (HP:0012120) | 2.50506369 |
| 74 | Macrocytic anemia (HP:0001972) | 2.49483325 |
| 75 | Degeneration of anterior horn cells (HP:0002398) | 2.46740590 |
| 76 | Abnormality of the anterior horn cell (HP:0006802) | 2.46740590 |
| 77 | Emotional lability (HP:0000712) | 2.41525478 |
| 78 | Hyperglycinemia (HP:0002154) | 2.39732618 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.38634054 |
| 80 | Syncope (HP:0001279) | 2.37864167 |
| 81 | Muscle fiber splitting (HP:0003555) | 2.37455588 |
| 82 | Vomiting (HP:0002013) | 2.34283173 |
| 83 | Aplastic anemia (HP:0001915) | 2.29207896 |
| 84 | Neoplasm of head and neck (HP:0012288) | 2.28125004 |
| 85 | Esophageal neoplasm (HP:0100751) | 2.28125004 |
| 86 | Nausea (HP:0002018) | 2.27179125 |
| 87 | Metabolic acidosis (HP:0001942) | 2.25704885 |
| 88 | X-linked dominant inheritance (HP:0001423) | 2.24672613 |
| 89 | Exertional dyspnea (HP:0002875) | 2.23442208 |
| 90 | Ketosis (HP:0001946) | 2.22758799 |
| 91 | Hyperammonemia (HP:0001987) | 2.20119745 |
| 92 | Hyperglycinuria (HP:0003108) | 2.16866326 |
| 93 | Multiple enchondromatosis (HP:0005701) | 2.16129365 |
| 94 | Subaortic stenosis (HP:0001682) | 2.14131158 |
| 95 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.14131158 |
| 96 | Microvesicular hepatic steatosis (HP:0001414) | 2.13670369 |
| 97 | EMG: myopathic abnormalities (HP:0003458) | 2.13524671 |
| 98 | Gliosis (HP:0002171) | 2.12022629 |
| 99 | Amniotic constriction ring (HP:0009775) | 2.09636466 |
| 100 | Abnormality of placental membranes (HP:0011409) | 2.09636466 |
| 101 | Reticulocytopenia (HP:0001896) | 2.07677119 |
| 102 | Nemaline bodies (HP:0003798) | 2.05633857 |
| 103 | Prolonged QT interval (HP:0001657) | 2.04719113 |
| 104 | Congenital, generalized hypertrichosis (HP:0004540) | 2.03786884 |
| 105 | Muscle stiffness (HP:0003552) | 2.02178073 |
| 106 | Abnormality of vitamin B metabolism (HP:0004340) | 2.01072466 |
| 107 | Myotonia (HP:0002486) | 2.00094410 |
| 108 | Rimmed vacuoles (HP:0003805) | 1.99032876 |
| 109 | Abnormality of glycine metabolism (HP:0010895) | 1.98530690 |
| 110 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.98530690 |
| 111 | Left ventricular hypertrophy (HP:0001712) | 1.97436203 |
| 112 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.95480144 |
| 113 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95212209 |
| 114 | Megaloblastic anemia (HP:0001889) | 1.94741750 |
| 115 | Ventricular arrhythmia (HP:0004308) | 1.94529130 |
| 116 | Right ventricular cardiomyopathy (HP:0011663) | 1.93562278 |
| 117 | Muscle fiber inclusion bodies (HP:0100299) | 1.90709971 |
| 118 | Renal cortical cysts (HP:0000803) | 1.90099751 |
| 119 | Colon cancer (HP:0003003) | 1.89792885 |
| 120 | Abnormality of renal resorption (HP:0011038) | 1.88573121 |
| 121 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.88137650 |
| 122 | Methylmalonic acidemia (HP:0002912) | 1.87142792 |
| 123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85469796 |
| 124 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84240897 |
| 125 | Hyperphosphaturia (HP:0003109) | 1.82584630 |
| 126 | Progressive external ophthalmoplegia (HP:0000590) | 1.82464829 |
| 127 | Pancytopenia (HP:0001876) | 1.80972044 |
| 128 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.78218542 |
| 129 | Abnormality of serum amino acid levels (HP:0003112) | 1.75804315 |
| 130 | Tinnitus (HP:0000360) | 1.75083224 |
| 131 | Oral leukoplakia (HP:0002745) | 1.73616931 |
| 132 | Hypothermia (HP:0002045) | 1.70776243 |
| 133 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.69818469 |
| 134 | Testicular atrophy (HP:0000029) | 1.67751995 |
| 135 | Gout (HP:0001997) | 1.60634895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.27258982 |
| 2 | VRK2 | 4.11456084 |
| 3 | MYLK | 3.95822346 |
| 4 | PDK3 | 3.66192603 |
| 5 | PDK4 | 3.66192603 |
| 6 | BCKDK | 3.63588344 |
| 7 | NEK1 | 3.28383787 |
| 8 | NME1 | 3.08004690 |
| 9 | NME2 | 2.73492122 |
| 10 | EIF2AK1 | 2.63495538 |
| 11 | BUB1 | 2.37863587 |
| 12 | PDK2 | 2.16641152 |
| 13 | MAP3K12 | 2.12743460 |
| 14 | STK24 | 2.10944984 |
| 15 | TTN | 2.10087328 |
| 16 | LMTK2 | 1.99166322 |
| 17 | STK16 | 1.95541435 |
| 18 | NUAK1 | 1.95271815 |
| 19 | PHKG1 | 1.93977444 |
| 20 | PHKG2 | 1.93977444 |
| 21 | SCYL2 | 1.88592171 |
| 22 | WEE1 | 1.85636381 |
| 23 | MAP4K2 | 1.72213825 |
| 24 | WNK4 | 1.60211874 |
| 25 | GRK7 | 1.60106390 |
| 26 | WNK3 | 1.58262019 |
| 27 | EIF2AK3 | 1.58045609 |
| 28 | ILK | 1.52616524 |
| 29 | STK38L | 1.46084936 |
| 30 | MST4 | 1.44108020 |
| 31 | MUSK | 1.40994268 |
| 32 | LIMK1 | 1.38991928 |
| 33 | ARAF | 1.38124681 |
| 34 | ZAK | 1.37909883 |
| 35 | TRIM28 | 1.27521817 |
| 36 | TSSK6 | 1.24726210 |
| 37 | TLK1 | 1.23438223 |
| 38 | PIK3CA | 1.23053607 |
| 39 | VRK1 | 1.18810700 |
| 40 | PINK1 | 1.17132986 |
| 41 | PBK | 1.13808943 |
| 42 | BRSK2 | 1.13150507 |
| 43 | CCNB1 | 1.11223563 |
| 44 | CSNK1G3 | 1.04440630 |
| 45 | PLK2 | 1.00407004 |
| 46 | TAF1 | 0.99729573 |
| 47 | MKNK1 | 0.98545982 |
| 48 | FLT3 | 0.95424996 |
| 49 | CDK8 | 0.94724999 |
| 50 | EIF2AK2 | 0.94394727 |
| 51 | OXSR1 | 0.93532609 |
| 52 | MAP2K7 | 0.90869469 |
| 53 | PKN2 | 0.89459676 |
| 54 | CSNK1G1 | 0.88843841 |
| 55 | TESK2 | 0.86874721 |
| 56 | TIE1 | 0.85671164 |
| 57 | STK39 | 0.85281927 |
| 58 | CAMK2D | 0.85099282 |
| 59 | ACVR1B | 0.83332618 |
| 60 | MAP3K4 | 0.83032050 |
| 61 | SRPK1 | 0.80728995 |
| 62 | BCR | 0.80315895 |
| 63 | BRAF | 0.78219461 |
| 64 | CSNK1G2 | 0.77728868 |
| 65 | ERBB3 | 0.76372428 |
| 66 | PAK4 | 0.76339431 |
| 67 | TNIK | 0.75933019 |
| 68 | CSNK1A1L | 0.74934494 |
| 69 | INSRR | 0.73788370 |
| 70 | MKNK2 | 0.73743724 |
| 71 | TESK1 | 0.71455274 |
| 72 | GRK1 | 0.71445903 |
| 73 | MAP2K4 | 0.70166556 |
| 74 | CHEK2 | 0.69369484 |
| 75 | GRK5 | 0.69295145 |
| 76 | PASK | 0.68608905 |
| 77 | PLK3 | 0.68506347 |
| 78 | ATR | 0.67779367 |
| 79 | DAPK3 | 0.65237140 |
| 80 | MAP3K3 | 0.63640912 |
| 81 | KDR | 0.61006246 |
| 82 | RPS6KA5 | 0.58762296 |
| 83 | PAK3 | 0.57673949 |
| 84 | CAMK2A | 0.57616964 |
| 85 | CAMK2G | 0.57451703 |
| 86 | PIM2 | 0.57098856 |
| 87 | PIK3CG | 0.56202427 |
| 88 | CDC7 | 0.56156520 |
| 89 | DAPK1 | 0.53435289 |
| 90 | ABL2 | 0.52807958 |
| 91 | CDK19 | 0.49267243 |
| 92 | RPS6KB2 | 0.49047182 |
| 93 | AURKB | 0.48521322 |
| 94 | PRKACA | 0.48263903 |
| 95 | BRSK1 | 0.46435803 |
| 96 | AURKA | 0.46025348 |
| 97 | PLK1 | 0.45825968 |
| 98 | CSNK2A1 | 0.45401973 |
| 99 | MAPKAPK5 | 0.45256377 |
| 100 | MAP3K5 | 0.43986556 |
| 101 | ADRBK1 | 0.43487510 |
| 102 | MAPKAPK3 | 0.42522318 |
| 103 | MAPK12 | 0.42308355 |
| 104 | ADRBK2 | 0.42035175 |
| 105 | MAP3K11 | 0.41669207 |
| 106 | CASK | 0.41295173 |
| 107 | ATM | 0.40748381 |
| 108 | PLK4 | 0.39633031 |
| 109 | BMPR1B | 0.38993565 |
| 110 | CAMK2B | 0.38223530 |
| 111 | GRK6 | 0.38181658 |
| 112 | CSNK2A2 | 0.37357722 |
| 113 | MAP2K6 | 0.36755936 |
| 114 | NEK2 | 0.34971127 |
| 115 | DYRK2 | 0.34803347 |
| 116 | MAP2K3 | 0.34777759 |
| 117 | TGFBR1 | 0.34437987 |
| 118 | PRKACB | 0.33686790 |
| 119 | NEK9 | 0.33472244 |
| 120 | CSNK1E | 0.33465930 |
| 121 | STK4 | 0.32992035 |
| 122 | BMPR2 | 0.32896747 |
| 123 | TTK | 0.32718932 |
| 124 | PRKCE | 0.32552736 |
| 125 | PTK2B | 0.30941805 |
| 126 | CDK7 | 0.30004302 |
| 127 | PRKCG | 0.29679998 |
| 128 | ROCK2 | 0.28902764 |
| 129 | PRKCI | 0.28222302 |
| 130 | AKT2 | 0.28194159 |
| 131 | CHEK1 | 0.27562546 |
| 132 | FRK | 0.26790145 |
| 133 | TAOK2 | 0.25463988 |
| 134 | ROCK1 | 0.25340494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.26231713 |
| 2 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.15477674 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.72233095 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.33479389 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.31893511 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.22771435 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 3.22397532 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.98623293 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.88752299 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.81435625 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.39473026 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.36068704 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.23249415 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.17555918 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07783543 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.79062338 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77650320 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68164383 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65297376 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56624988 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.52457290 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.50033592 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.47781982 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44160270 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43475080 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39836095 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.12298224 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11168549 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11043807 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10349427 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.09352884 |
| 32 | DNA replication_Homo sapiens_hsa03030 | 1.08652526 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03230776 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01143673 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.00047028 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97811779 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93752343 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93688689 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91663296 |
| 40 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.88103098 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87056533 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85207124 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79694572 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79637169 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79620245 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78627318 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76109149 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73119842 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72430311 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71417465 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69876349 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.69199660 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68952938 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67526186 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67257439 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65420836 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65060695 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62682541 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62156803 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 0.60334443 |
| 61 | RNA transport_Homo sapiens_hsa03013 | 0.59299606 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59283810 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57449137 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57024835 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53629737 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.53433954 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.53280456 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52141660 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50710830 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.47420019 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47400858 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46534650 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43462725 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41767928 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40595402 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40590414 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38564299 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37032904 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35465863 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33745452 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33287602 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32938807 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32487888 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30373656 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29584723 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.28878786 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.28753098 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28106960 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.28060492 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26473423 |
| 91 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.25393767 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24825109 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24383083 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24160157 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22941120 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22736967 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.22545980 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21888914 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21710749 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20668000 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17143773 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.17120409 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.16318358 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.12992228 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.12981367 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.12083046 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.11894974 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.11752793 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.07664746 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.05372665 |
| 111 | Cell cycle_Homo sapiens_hsa04110 | 0.03237656 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.02867092 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.02341438 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.01344860 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.01218327 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0176906 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0159005 |

